Emerging & Hybrid IPAI & Future
Regenerative Medicine (iPS Cells)
Popularity개요
Japan's regenerative medicine research based on Professor Shinya Yamanaka's iPS cell technology. Since the 2012 Nobel Prize, clinical applications have steadily advanced. Japan leads the world in practical iPS cell treatments for retinal diseases, heart disease, and Parkinson's disease.
※ 이 내용은 편집부 AI가 공개 정보를 바탕으로 생성한 아이디어입니다.
메타데이터
카테고리:Emerging & Hybrid IP
서브카테고리:AI & Future
소재지:Kyoto (Kyoto University)
시대:2006-present
영향 범위:세계
태그
iPS CellsRegenerative MedicineNobel Prize
Explore by Tag
Contemporary IPs
2006Regenerative Medicine (iPS Cells)Emerging & Hybrid IP
Recent News
Loading...
📱 Share on Social
Discovered: Regenerative Medicine (iPS Cells)! Japan's regenerative medicine research based on Professor Shinya Yamanaka's iPS … #iPSCells #RegenerativeMedicine #NobelPrize #JAPANIPCATALYST #JapanCulture
